about
Computational systems analysis of dopamine metabolismDopamine covalently modifies and functionally inactivates parkinMethamphetamine toxicity and messengers of deathSelective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's diseaseClinical review: immunomodulatory effects of dopamine in general inflammationCatecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disordersGenetically engineered mouse models of Parkinson's diseaseSelenoproteins in nervous system development and functionProtection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson's diseaseIncreased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits.Cell-permeable parkin proteins suppress Parkinson disease-associated phenotypes in cultured cells and animalsThe nigrostriatal dopamine system of aging GFRalpha-1 heterozygous mice: neurochemistry, morphology and behaviorCyclin-dependent kinase 5 phosphorylates serine 31 of tyrosine hydroxylase and regulates its stabilityThe Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons.Molecular cloning, localization and characterization of a 40-kDa catecholamine-regulated protein.Chemistry of periodate-mediated cross-linking of 3,4-dihydroxylphenylalanine-containing molecules to proteins.E3 Ubiquitin Ligases Neurobiological Mechanisms: Development to DegenerationReduced antioxidant defense in early onset first-episode psychosis: a case-control study.skn-1-Dependent and -independent regulation of aip-1 expression following metabolic stress in Caenorhabditis elegans.Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release.Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients.The AS/AGU rat: a spontaneous model of disruption and degeneration in the nigrostriatal dopaminergic system.Mice lacking multidrug resistance protein 1a show altered dopaminergic responses to methylenedioxymethamphetamine (MDMA) in striatumParkin and alpha-synuclein: opponent actions in the pathogenesis of Parkinson's disease.Neuroprotection for Parkinson's disease: a new approach for a new millennium.Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease.Drosophila models of Parkinson's disease: discovering relevant pathways and novel therapeutic strategies.Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging.Ozone inhalation modifies the rat liver proteome.Characterization of reduced and oxidized dopamine and 3,4-dihydrophenylacetic acid, on brain mitochondrial electron transport chain activities.Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite.A dopamine receptor contributes to paraquat-induced neurotoxicity in Drosophila.Oxidation of 3,4-dihydroxyphenylacetaldehyde, a toxic dopaminergic metabolite, to a semiquinone radical and an ortho-quinone.A neuroinductive biomaterial based on dopamine.Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat.Methylmercury impairs canonical dopamine metabolism in rat undifferentiated pheochromocytoma (PC12) cells by indirect inhibition of aldehyde dehydrogenase.Inflammation as a causative factor in the aetiology of Parkinson's diseaseRenal-dose dopamine: from hypothesis to paradigm to dogma to myth and, finally, superstition?Cell systems and the toxic mechanism(s) of alpha-synucleinOxidative stress biomarkers in some rat brain structures and peripheral organs underwent cocaine
P2860
Q21144295-4DF3DAA8-D1F0-4E33-ACE4-0FF5DBCD1B88Q24338423-850B9462-DE64-42B0-9D6F-3075CDDFE200Q24647617-2E130E22-44C6-458C-8DEB-305434686F85Q24794457-F795ED1F-BC1E-4395-AAD1-40ECBF3B7B26Q24800544-240FA1F3-CE41-4A12-881E-647D9CD601F2Q26826093-2A3B1554-9352-4263-BFCB-086431EC7A44Q26852964-989948EC-F1B4-41D0-97E4-E76DBDD68988Q27009087-C4F5B681-573D-486C-986D-777AAB4F5C25Q27302176-3E776EC9-0BA4-40A0-A161-0CDE2243CB2AQ27308109-741EAE76-5642-4110-8FDA-7C75DDD18A8DQ27318797-8C24C145-7E82-4186-AA5A-16236634FF93Q28510989-E53B6B50-D6ED-4EA0-9B70-F34A2F3C37DEQ28571192-620DAF13-EDDD-4680-8D2F-76BE032A5899Q30430534-996C5452-9974-41B9-B3AC-096475CC2219Q31962096-AC56011C-A216-41E0-8537-75C282A74108Q33264179-1064BF90-6D3D-46C2-A52B-8AFAD444DA40Q33705444-FA725204-66B8-41D6-B469-8A382AB129EDQ33820188-A9032800-708C-434C-B418-9919CE52DFC1Q33876975-96478ED8-46FF-440B-8B6C-9A9CDF7F17A2Q33913079-8A880F04-F592-46F1-9B86-81857E04648DQ33979025-E9A52935-DCD5-4128-A13F-977EDBA107DFQ33989384-A9C932EA-F61E-4844-BA38-A6DDDF1C514AQ34051713-2041C51F-BCC2-4A33-A58F-A350E3918883Q34301507-126205C5-6BFA-4AC4-9EF7-18EA64B78B88Q34481778-06CFF95B-493C-474D-8C5A-77BECA0332A1Q34547466-A77E5E1A-7F0F-48B2-AF9E-321D34634EC3Q34787767-A53DBD99-4967-46B0-A0E1-C84418CCF95DQ34944292-D42D84F9-34A0-4F7A-A904-2CC982AFA7A5Q34980938-3465BCC0-A383-4D22-B880-93DC10AB6AE0Q35024921-F80CC65A-5C6E-46A7-B7B0-49FB7E0D61F7Q35028427-D8FE51DA-CE13-4222-BA12-2781C104F681Q35078638-A3D79FFE-628C-4073-866A-CCD9438F3A37Q35128313-E3DE68DA-1F1D-4397-993C-7353A9046150Q35130661-AADF6156-1A7E-4F52-9311-AC8C8C3C85A9Q35212580-399A16D6-A3A7-48BA-B9CF-EC51596DE1B2Q35214603-70258C96-9904-4365-8EA2-50A70B440AD0Q36052641-3D580700-FE39-40EE-A28F-59AC2E58F259Q36215373-F54B3241-C263-438C-AB05-3E9FC5A8283EQ36440972-0258BD88-F174-4110-8E6D-FD6D505BC85FQ36479087-523F657A-F4B8-418E-B468-718317393AB6
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cytotoxic and genotoxic potential of dopamine.
@ast
Cytotoxic and genotoxic potential of dopamine.
@en
type
label
Cytotoxic and genotoxic potential of dopamine.
@ast
Cytotoxic and genotoxic potential of dopamine.
@en
prefLabel
Cytotoxic and genotoxic potential of dopamine.
@ast
Cytotoxic and genotoxic potential of dopamine.
@en
P2093
P2860
P1476
Cytotoxic and genotoxic potential of dopamine.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C
P577
1999-03-01T00:00:00Z